Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.

about

Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.

Item

http://www.wikidata.org/entity/Q42094433

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.

@en

Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.

@nl

type

Item

label

Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.

@en

Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.

@nl

prefLabel

Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.

@en

Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.

@nl

P1476

Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions

@en

P2093

Bergur Stefansson

http://www.w3.org/2001/XMLSchema#string

Marie Ahlqvist

http://www.w3.org/2001/XMLSchema#string

Marie Elebring

http://www.w3.org/2001/XMLSchema#string

Mikael Knutsson

http://www.w3.org/2001/XMLSchema#string

Susanne Johansson

http://www.w3.org/2001/XMLSchema#string

P2860

Stool form scale as a useful guide to intestinal transit time

Molecular cloning of putative members of the Na/H exchanger gene family. cDNA cloning, deduced amino acid sequence, and mRNA tissue expression of the rat Na/H exchanger NHE-1 and two structurally related proteins.

Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial.

A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers.

Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans.

Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD.

Cytochrome P450-mediated metabolism in the human gut wall.

Characterization of human small intestinal cytochromes P-450.

Effect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis.

Defective jejunal and colonic salt absorption and alteredNa(+)/H (+) exchanger 3 (NHE3) activity in NHE regulatory factor 1 (NHERF1) adaptor protein-deficient mice

P304

466-475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPDD.346

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Helen Rollison

David P Rosenbaum

P577

2017-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28301096

http://www.w3.org/2001/XMLSchema#string

P932

5599994

http://www.w3.org/2001/XMLSchema#string